HSPH1 and cancer: Given the pathogenic effect of activated STAT3 after forming a complex with Hsp110 in the progression of cancer and the advantage of PPI inhibitors in the treatment of diseases [22, 28, 29], we preliminarily evaluated their activities on the downstream STAT3 pathway in HPAECs.